The association of delta neutrophil index with the prognosis of acute exacerbation of chronic obstructive pulmonary disease

被引:9
|
作者
Park, Sunmin [1 ]
Lee, Sang Jun [1 ]
Shin, Beomsu [1 ]
Lee, Seok Jeong [1 ]
Kim, Sang-Ha [1 ]
Kwon, Woo Cheol [2 ]
Kim, Jihye [3 ]
Lee, Myoung Kyu [1 ,4 ]
机构
[1] Yonsei Univ, Wonju Coll Med, Dept Internal Med, 20 Ilsan Ro, Wonju 26426, Gangwon Do, South Korea
[2] Yonsei Univ, Wonju Coll Med, Dept Radiol, Wonju, Gangwon, South Korea
[3] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL USA
[4] Yonsei Univ, Wonju Coll Med, Dept Evidence Based Med, Wonju, Gangwon, South Korea
关键词
Acute exacerbation; Chronic obstructive pulmonary disease; Community-acquired pneumonia; Delta neutrophil index; Mortality; Readmission; COMMUNITY-ACQUIRED PNEUMONIA; COPD; MORTALITY; GUIDELINES; MANAGEMENT; DIAGNOSIS; SEPSIS; COUNTS; MARKER; ADULTS;
D O I
10.1186/s12890-020-1083-4
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with infective triggers including bacterial or viral in many cases, and pneumonia is a major contributor to hospitalization for AECOPD and has a close relationship with poor outcomes. Increased delta neutrophil index (DNI) can be useful in the detection of COPD patients with pneumonia. Methods A retrospective cohort study was performed to investigate the mortality rate of the patients who were re-admitted within 6 months after discharge from the hospital due to AECOPD with or without CAP. We analyzed the difference of cumulative survival rate according to serum DNI level and readmission duration. Results Finally, 140 AECOPD patients with community-acquired pneumonia (CAP) and 174 AECOPD patients without CAP were enrolled during 6 months, respectively. The mean age was 72.2 +/- 9.4 year-old, and 240 patients (76.4%) were male. When comparing the cumulative survival rate according to readmission duration (<= 30 vs > 30 days) and DNI level (< 3.5 vs >= 3.5%), AECOPD patients with readmission <= 30 days and DNI >= 3.5% showed the lowest cumulative survival rate compared to other groups (P < 0.001). Multivariate analysis revealed readmission duration <= 30 days (HR 7.879, 95% CI 4.554-13.632, P < 0.001); and serum DNI level (HR 1.086, 95% CI 1.043-1.131, P < 0.001) were significantly associated with the mortality of AECOPD patients during 6 months. The area under the curve for readmission (<= 30 days) + DNI level (>= 3.5%) was 0.753 (95% CI 0.676-0.830, P < 0.001) with a sensitivity of 73.7% and a specificity of 67.3%. Conclusion AECOPD patients who were readmitted <= 30 days and DNI >= 3.5% showed higher mortality. DNI level can be used as a predictor of prognosis in AECOPD patients who were readmitted after discharge.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Prevalence of pulmonary aspergillosis among chronic obstructive pulmonary disease patients presented with acute exacerbation
    Shawki, Mostafa
    Abdel-Hamid, H. M.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2019, 68 (02): : 129 - 134
  • [12] Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease
    Teng, Fei
    Ye, Huan
    Xue, Tianjiao
    PLOS ONE, 2018, 13 (09):
  • [13] Computed tomography manifestation of acute exacerbation of chronic obstructive pulmonary disease: A pilot study
    Cheng, Ting
    Wan, Huanying
    Cheng, Qijian
    Guo, Yi
    Qian, Yanrong
    Fan, Liang
    Feng, Yun
    Song, Yanyan
    Zhou, Min
    Li, Qingyun
    Shi, Guochao
    Huang, Shaoguang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (02) : 519 - 529
  • [14] Acute Exacerbation According to GOLD 2017 Categories in Patients with Chronic Obstructive Pulmonary Disease
    Kim, Joohae
    Lee, Chang-Noon
    Lee, Myung-Goo
    Shin, Kyeong-Cheol
    Yoo, Kwang Ha
    Lim, Seong Yong
    Na, Ju Ock
    Yoo, Chul-Gyu
    Jung, Ki Suck
    Lee, Sang-Do
    ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (08): : 414 - 420
  • [15] Prehospital prognosis is difficult in patients with acute exacerbation of chronic obstructive pulmonary disease
    Katrine P. Lindvig
    Anne C. Brøchner
    Annmarie T. Lassen
    Søren Mikkelsen
    Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 25
  • [16] Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients
    Taylan, Mahsuk
    Demir, Melike
    Kaya, Halide
    Sen, Hadice Selimoglu
    Abakay, Ozlem
    Carkanat, Ali Ihsan
    Abakay, Abdurrrahman
    Tanrikulu, Abdullah Cetin
    Sezgi, Cengizhan
    CLINICAL RESPIRATORY JOURNAL, 2017, 11 (03): : 311 - 317
  • [17] Adequacy and prognostic impact of treatment for severe exacerbation of chronic obstructive pulmonary disease
    Portoles-Callejon, A.
    Lopez-Alfaro, R.
    Gimenez-Miranda, L.
    Lopez-Rios, M. C.
    Varela-Aguilar, J. M.
    Calderon, E.
    Medrano, F. J.
    REVISTA CLINICA ESPANOLA, 2020, 220 (07): : 417 - 425
  • [18] Bronchial asthma and chronic obstructive pulmonary disease with acute exacerbation
    Friege, B.
    Friege, L.
    Pelz, J.
    Weber, M.
    von Spiegel, T.
    Schroeder, S.
    ANAESTHESIST, 2009, 58 (06): : 611 - +
  • [19] Lactate dehydrogenase to albumin ratio and prognosis in patients with acute exacerbation of chronic obstructive pulmonary disease: a retrospective cohort study
    Ding, Chao-Wei
    Huang, Shen-Shen
    Xu, Yan-Hong
    Chu, Xu
    Wang, Lan
    Mao, Yi-Min
    Yuan, Ya-Dong
    Qiu, Jia-Yong
    BMC PULMONARY MEDICINE, 2025, 25 (01):
  • [20] Efficacy and safety of single-dose 2.0 g azithromycin in the treatment of acute exacerbation of chronic obstructive pulmonary disease
    Asai, Nobuhiro
    Ohkuni, Yoshihiro
    Iwasaki, Takuya
    Matsunuma, Ryo
    Nakashima, Kei
    Otsuka, Yoshihito
    Kaneko, Norihiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (06) : 793 - 798